Year |
Citation |
Score |
2014 |
Gatalica Z, Snyder C, Maney T, Ghazalpour A, Holterman DA, Xiao N, Overberg P, Rose I, Basu GD, Vranic S, Lynch HT, Von Hoff DD, Hamid O. Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2965-70. PMID 25392179 DOI: 10.1158/1055-9965.EPI-14-0654 |
0.336 |
|
2014 |
Gatalica Z, Snyder CL, Yeatts K, Xiao N, Holterman D, Lynch HT. Programmed death 1 (PD-1) lymphocytes and ligand (PD-L1) in colorectal cancer and their relationship to microsatellite instability status. Journal of Clinical Oncology. 32: 3625-3625. DOI: 10.1200/Jco.2014.32.15_Suppl.3625 |
0.303 |
|
2012 |
Smith SE, Holterman DA, Brown KM, Duncan JE, Zhong J, Stark A, Millis M, Tinder T, Spetzler D. Abstract 3607: Differential protein expression and miR content of sorted subsets of circulating microvesicles from cancer patients and healthy controls Cancer Research. 72: 3607-3607. DOI: 10.1158/1538-7445.Am2012-3607 |
0.31 |
|
2011 |
Deng T, Spetzler DB, Holterman D, Pawlowski T, Duncan JE, Smith SE, Radebach K, LIttle T, Kuslich CD. Abstract 444: Subpopulations of circulating microvesicles have different microRNA profiles Cancer Research. 71: 444-444. DOI: 10.1158/1538-7445.Am2011-444 |
0.301 |
|
2011 |
Spetzler DB, Deng T, Tinder T, Kimbrough J, Ellis P, Holterman D, Maney T, Kuslich CD. Abstract 4060: Enriching for rrare subpopulations of circulating microvesicles by the depletion of endothelial- and leukocyte-derived microvesicles Cancer Research. 71: 4060-4060. DOI: 10.1158/1538-7445.Am2011-4060 |
0.354 |
|
2011 |
Holterman DA, Duncan JE, Deng T, Smith SE, Spetzler DB, Kuslich CD. Abstract 1568: Plasma-derived circulating microvesicles can both detect and help monitor breast cancer-related pathologies Cancer Research. 71: 1568-1568. DOI: 10.1158/1538-7445.Am2011-1568 |
0.371 |
|
2006 |
Holterman DA, Diaz JI, Blackmore PF, Davis JW, Schellhammer PF, Corica A, Semmes OJ, Vlahou A. Overexpression of alpha-defensin is associated with bladder cancer invasiveness. Urologic Oncology. 24: 97-108. PMID 16520271 DOI: 10.1016/J.Urolonc.2005.07.010 |
0.349 |
|
2004 |
Ciavarra RP, Holterman DA, Brown RR, Mangiotti P, Yousefieh N, Wright GL, Schellhammer PF, Glass WF, Somers KD. Prostate tumor microenvironment alters immune cells and prevents long-term survival in an orthotopic mouse model following flt3-ligand/CD40-ligand immunotherapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 27: 13-26. PMID 14676630 DOI: 10.1097/00002371-200401000-00002 |
0.575 |
|
2003 |
Ciavarra RP, Brown RR, Holterman DA, Garrett M, Glass WF, Wright GL, Schellhammer PF, Somers KD. Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancer. Cancer Immunology, Immunotherapy : Cii. 52: 535-45. PMID 14627125 DOI: 10.1007/S00262-003-0383-X |
0.69 |
|
2003 |
Somers KD, Brown RR, Holterman DA, Yousefieh N, Glass WF, Wright GL, Schellhammer PF, Qian J, Ciavarra RP. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy. International Journal of Cancer. Journal International Du Cancer. 107: 773-80. PMID 14566827 DOI: 10.1002/Ijc.11464 |
0.56 |
|
Show low-probability matches. |